Related references
Note: Only part of the references are listed.I2/Li2CO3-promoted cyanation of diarylalcohols through a dual activation process
Liangzhen Hu et al.
TETRAHEDRON (2019)
Design and synthesis of a biaryl series as inhibitors for the bromodomains of CBP/P300
Kwong Wah Lai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Input of P, N-(phosphanyl, amino)-ferrocene hybrid derivatives in late transition metals catalysis
Nejib Dwadnia et al.
COORDINATION CHEMISTRY REVIEWS (2018)
Immobilization of an Aminobisphosphine-Pd-II Complex over Graphene Oxide: An Efficient and Reusable Catalyst for Suzuki-Miyaura, Ullmann Coupling and Cyanation Reactions
Debasish Sengupta et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2018)
4-Aminopyrimidine libraries from the Ugi-Smiles reaction of thiouracil
Madjid Ait Sidhoum et al.
TETRAHEDRON (2018)
The Bismarck Brown Y based functional polymer-bound palladium nanoparticles as a capable catalyst for the synthesis of N-arylsulfonyl cyanamides
Somayyeh Heydari et al.
POLYHEDRON (2018)
Integrated Pd-catalyzed cross-coupling strategies for furnishing α-carbolines
Misayo Sera et al.
TETRAHEDRON (2017)
Selective Access to 3-Cyano-1H-indoles, 9H-Pyrimido[4,5-b]indoles, or 9H-Pyrido[2,3-b]indoles through Copper-Catalyzed One-Pot Multicomponent Cascade Reactions
Bin Li et al.
JOURNAL OF ORGANIC CHEMISTRY (2015)
Recent developments and perspectives in palladium-catalyzed cyanation of aryl halides: synthesis of benzonitriles
Pazhamalai Anbarasan et al.
CHEMICAL SOCIETY REVIEWS (2011)
A convenient route to functionalized 3-amino-N-methylfuro[3,2-b]pyridine-2-carboxamides
Anne Breteche et al.
TETRAHEDRON (2011)
Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Recent Applications of Palladium-Catalyzed Coupling Reactions in the Pharmaceutical, Agrochemical, and Fine Chemical Industries
Christian Torborg et al.
ADVANCED SYNTHESIS & CATALYSIS (2009)
Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557
A. Schmitt-Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Neratinib: an oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer
Prithviraj Bose et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression
Arif Khan
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
Richard E. Pratley
EXPERT OPINION ON PHARMACOTHERAPY (2009)
New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir
Christine A. Hughes et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
In Vitro Antifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries
P. E. Verweij et al.
JOURNAL OF CHEMOTHERAPY (2009)
Chelation-Assisted Palladium-Catalyzed Cascade Bromination/Cyanation Reaction of 2-Arylpyridine and 1-Arylpyrazole C-H Bonds
Xiaofei Jia et al.
JOURNAL OF ORGANIC CHEMISTRY (2009)
Febuxostat
Eliseo Pascual et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Chelation-Assisted Palladium-Catalyzed Direct Cyanation of 2-Arylpyridine C-H Bonds
Xiaofei Jia et al.
ORGANIC LETTERS (2009)
The Efficacy and Safety of Cilomilast in COPD
Stephen Rennard et al.
DRUGS (2008)
Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days
Jeremy P. Nuttall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Recent advances in antifungal chemotherapy
George Petrikkos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
The discovery and mechanism of action of letrozole
Ajay S. Bhatnagar
BREAST CANCER RESEARCH AND TREATMENT (2007)
Dual irreversible kinase inhibitors: Quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2
Allan Wissner et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Spotlight on bicalutamide 150mg in the treatment of locally advanced prostate cancer
Keri Wellington et al.
DRUGS & AGING (2007)
Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCVNS5B polymerase:: From benzimidazole to indole scaffolds
Pierre L. Beaulieu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
The pharmacology of citalopram enantiomers:: The antagonism by R-citalopram on the effect of S-citalopram
Connie Sanchez
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors
Charles Erlichman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors
E. Munoz-Islas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
From cromakalim to different structural classes of K-ATP channel openers
Violetta Cecchetti et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome
P Lemoine et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
A practical synthesis of highly functionalized aryl nitriles through cyanation of aryl bromides employing heterogeneous Pd/C: in quest of an industrially viable process
M Hatsuda et al.
TETRAHEDRON (2005)
Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome
JD Favre et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2005)
Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes
M Bayram et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget
A Fensome et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
EL Kwak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
New insights in postoperative pain therapy
A Brack et al.
ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE (2004)
In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides
Y Van Herrewege et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Palladium-catalyzed cyanation of aryl halides: Recent developments and perspectives
M Sundermeier et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2003)
Donitriptan selectively decreases jugular venous oxygen saturation in the anesthetized pig:: Further insights into its mechanism of action relevant to headache relief
R Létienne et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
6-sulfonylchromenes as highly potent KATP-channel openers
E Salamon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Pharmacodynamic profile of zaleplon, a new non-benzodiazepine hypnotic agent
A Patat et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2001)
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans
T Yamazumi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)